C12Y 204/01133
Xylosylprotein 4-beta-galactosyltransferase
Official title: Xylosylprotein 4-beta-galactosyltransferase (2.4.1.133)
C12Y204/01133 (Xylosylprotein 4-beta-galactosyltransferase) appears on 7 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 12
- Assignees
- 11
- Inventors
- 26
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- B4GALT1 variants and uses thereof25 Nov 2025US 12,480,103 B2Regeneron Pharmaceuticals, Inc.
- Yeast strains producing mammalian-like complex n-glycans18 Jan 2022US 11,225,646 B2Oxyrane UK Limited
- B4GALT1 cDNA variants and compositions comprising the same11 Aug 2020US 10,738,284 B2Regeneron Pharmaceuticals, Inc.
- Yeast strains producing mammalian-like complex N-glycans14 May 2019US 10,287,557 B2Oxyrane UK Limited
- Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity31 Mar 2015US 8,993,297 B2Centre National De La Recherche Scientifique
- B4GALT1 Variants And Uses Thereof23 Jul 2026US 2026/0209720 A1Regeneron Pharmaceuticals, Inc.
- Cell lines with improved aav production capacity16 Jan 2025US 2025/0019669 A1The Children’s Hospital of Philadelphia
- Site-Specific Modification of Glycoproteins Through Transglutaminase-Mediated Conjugation6 Jun 2024US 2024/0182586 A1Northeastern University
- B4GALT1 Variants And Uses Thereof24 Dec 2020US 2020/0399617 A1Regeneron Pharmaceuticals, Inc.
- Yeast strains producing mammalian-like complex n-glycans1 Aug 2019US 2019/0233802 A1Oxyrane UK Limited
Most cited
By later US patents
- Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity12US 8,993,297 B2Centre National De La Recherche Scientifique · 2015
- Surface expression vectors having pgsBCA the gene coding poly-gamma-glutamate synthetase, and a method for expression of target protein at the surface of microorganism using the vector8US 7,553,636 B2Bioleaders Corporation · 2009
- Yeast strains producing mammalian-like complex N-glycans4US 10,287,557 B2Oxyrane UK Limited · 2019